Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10189831 Non-nucleoside reverse transcriptase inhibitors
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 11 Sep, 2024
"update inverses"
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12084663 Incorporation of unnatural amino acids into proteins using base editing
0
Edits on 25 Jul, 2024
"update inverses"
Golden AI
edited on 25 Jul, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
0
Edits on 6 Jun, 2024
"update inverses"
Golden AI
edited on 6 Jun, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11999947 Adenosine nucleobase editors and uses thereof
0
Edits on 21 Mar, 2024
"update inverses"
Golden AI
edited on 21 Mar, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11932884 High efficiency base editors comprising Gam
0
Edits on 2 Mar, 2024
"update inverses"
Golden AI
edited on 2 Mar, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11912985 Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
0
Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article
(
+38
characters)
Article
Patent abstract
Compounds of Formula I:
Edits on 19 Jul, 2023
"update inverses"
Golden AI
edited on 19 Jul, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11702651 Adenosine nucleobase editors and uses thereof
0
Edits on 5 Jul, 2023
"update inverses"
Golden AI
edited on 5 Jul, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11691969 Pyridazinones as PARP7 inhibtors
0
Edits on 31 May, 2023
"update inverses"
Golden AI
edited on 31 May, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11661590 Programmable CAS9-recombinase fusion proteins and uses thereof
0
Edits on 10 May, 2023
"update inverses"
Golden AI
edited on 10 May, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11643652 Methods and compositions for prime editing nucleotide sequences
0
Edits on 29 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 29 Apr, 2023
Infobox
Patent Citations Received
US Patent 11319532 High efficiency base editors comprising Gam
0
Edits on 6 Apr, 2023
"Entity importer update"
Golden AI
edited on 6 Apr, 2023
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10189831
0
Date of Patent
January 29, 2019
0
Patent Application Number
15616756
0
Date Filed
June 7, 2017
0
Patent Citations Received
US Patent 11268082 Nucleobase editors comprising nucleic acid programmable DNA binding proteins
0
US Patent 11306324 AAV delivery of nucleobase editors
0
US Patent 11319532 High efficiency base editors comprising Gam
0
US Patent 11447770 Methods and compositions for prime editing nucleotide sequences
0
US Patent 11542496 Cytosine to guanine base editor
0
US Patent 11542509 Incorporation of unnatural amino acids into proteins using base editing
0
US Patent 11560566 Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
0
US Patent 11566020 Pyridazinones as PARP7 inhibitors
0
Patent Primary Examiner
Jean P Cornet
0
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 28 Mar, 2023
Infobox
Patent Citations Received
US Patent 11542496 Cytosine to guanine base editor
0
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 28 Mar, 2023
Infobox
Patent Citations Received
US Patent 11268082 Nucleobase editors comprising nucleic acid programmable DNA binding proteins
0
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 22 Mar, 2023
Infobox
Patent Citations Received
US Patent 11542509 Incorporation of unnatural amino acids into proteins using base editing
0
Edits on 1 Feb, 2023
"update inverses"
Golden AI
edited on 1 Feb, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11566020 Pyridazinones as PARP7 inhibitors
0
Edits on 25 Jan, 2023
"update inverses"
Golden AI
edited on 25 Jan, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11560566 Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
0
Edits on 4 Jan, 2023
"update inverses"
Golden AI
edited on 4 Jan, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11542509 Incorporation of unnatural amino acids into proteins using base editing
0
"update inverses"
Golden AI
edited on 4 Jan, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11542496 Cytosine to guanine base editor
0
Edits on 28 Sep, 2022
"Entity importer update"
Golden AI
edited on 28 Sep, 2022
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10189831
0
Date of Patent
January 29, 2019
0
Patent Application Number
15616756
0
Date Filed
June 7, 2017
0
Patent Citations Received
US Patent 11268082 Nucleobase editors comprising nucleic acid programmable DNA binding proteins
0
US Patent 11306324 AAV delivery of nucleobase editors
0
US Patent 11319532 High efficiency base editors comprising Gam
0
US Patent 11447770 Methods and compositions for prime editing nucleotide sequences
0
Patent Primary Examiner
Jean P Cornet
0
Load more
Find more entities like US Patent 10189831 Non-nucleoside reverse transcriptase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE